Literature DB >> 12789385

Under-reporting of erectile dysfunction among men with unrelated urologic conditions.

K Baldwin1, P Ginsberg, R C Harkaway.   

Abstract

To evaluate the incidence of erectile dysfunction (ED) in men with unrelated urologic conditions paying special attention to the reasons for patient under-reporting. We asked 500 consecutive men over age 50 visiting their urologist's office for problems unrelated to ED, whether or not they had any difficulty with their potency. Those who gave a positive response were then asked to complete a questionnaire to assess their reasons for under-reporting and whether they had had any previous discussions with their primary-care physicians regarding their sexual function. Out of 500 men, 218 (44%) reported experiencing some degree of ED. Reasons for failure to discuss ED with their urologist included: 161 out of 218 (74%) were embarrassed; 27 out of 218 (12%) felt that ED was a natural part of aging; 20 out of 218 (9%) were unaware that urologists dealt with the problem of ED; and 10 out of 218 (5%) did not consider the problem worthy of attention. Only 48 of the 218 men with ED reported having previous discussions about their problem with their primary-care physicians. Of the 170 patients who did not report having such discussions, 140 (82%) reported that they would have liked their primary-care physician to have initiated a discussion of ED during their routine visits. In conclusion. a significant percentage of older men with some unrelated urologic complaint also suffer from some degree of ED and remain undiagnosed unless specifically questioned about this problem. By far, the most common reason for under-reporting of ED was patient embarrassment. While urologists are able to elicit information regarding erectile function on specific questioning, patients appear comfortable and willing to discuss their potency with primary-care physicians.

Entities:  

Mesh:

Year:  2003        PMID: 12789385     DOI: 10.1038/sj.ijir.3900948

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  12 in total

1.  Patient experiences with communication about sex during and after treatment for cancer.

Authors:  Kathryn E Flynn; Jennifer Barsky Reese; Diana D Jeffery; Amy P Abernethy; Li Lin; Rebecca A Shelby; Laura S Porter; Carrie B Dombeck; Kevin P Weinfurt
Journal:  Psychooncology       Date:  2011-03-10       Impact factor: 3.894

2.  Determinants of male reproductive health disorders: the Men in Australia Telephone Survey (MATeS).

Authors:  Carol A Holden; Robert I McLachlan; Marian Pitts; Robert Cumming; Gary Wittert; Johnathon P Ehsani; David M de Kretser; David J Handelsman
Journal:  BMC Public Health       Date:  2010-02-24       Impact factor: 3.295

Review 3.  Testosterone deficiency in the aging male.

Authors:  J Abram McBride; Culley C Carson; Robert M Coward
Journal:  Ther Adv Urol       Date:  2016-02

4.  An Analysis of Popular Online Erectile Dysfunction Supplements.

Authors:  Adithya Balasubramanian; Nannan Thirumavalavan; Ashwin Srivatsav; Justin Yu; James M Hotaling; Larry I Lipshultz; Alexander W Pastuszak
Journal:  J Sex Med       Date:  2019-04-26       Impact factor: 3.937

5.  Prevalence, correlates, attitude and treatment seeking of erectile dysfunction among type 2 diabetic Chinese men attending primary care outpatient clinics.

Authors:  Wai Hon Lo; Sau Nga Fu; Carlos King Ho Wong; Ee San Chen
Journal:  Asian J Androl       Date:  2014 Sep-Oct       Impact factor: 3.285

6.  Prevalence of, and risk factors for erectile dysfunction in male type 2 diabetic outpatient attendees in Enugu, South East Nigeria.

Authors:  Fred O Ugwumba; Christian I Okafor; Ikenna I Nnabugwu; Emeka I Udeh; Kevin N Echetabu; Agharighom D Okoh; John C Okorie
Journal:  Ann Afr Med       Date:  2018 Oct-Dec

7.  Breaking the Ice of Erectile Dysfunction Taboo: A Focus on Clinician-Patient Communication.

Authors:  Tariq F Al-Shaiji
Journal:  J Patient Exp       Date:  2022-01-31

Review 8.  Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors:  R Sadovsky; G B Brock; S W Gutkin; S Sorsaburu
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503

9.  Erectile Dysfunction in Brazilian Primary Health Care: Dealing with Medicalization.

Authors:  Antônio Augusto Dall'Agnol Modesto; Marcia Thereza Couto
Journal:  Am J Mens Health       Date:  2017-10-27

10.  Management of erectile dysfunction after prostate cancer treatment: cross-sectional surveys of the perceptions and experiences of patients and healthcare professionals in the UK.

Authors:  Amy Dyer; Mike Kirby; Isabel D White; Alison Michelle Cooper
Journal:  BMJ Open       Date:  2019-10-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.